Answers are grounded in this paper and cite their sources.
Chiral Ruthenium–diphosphine–diamine complexes with a siloxy pendant are grafted onto mesoporous silica nanospheres. The resulting supported ruthenium catalysts are highly active for the asymmetric hydrogenation of aromatic ketones to afford chiral secondary alcohols and racemic aryl aldehydes to give chiral primary alcohols (see scheme). This immobilization strategy should be amenable to the design of similar heterogeneous catalysts.
No takes yet. Share an insight, caveat, or question.
Mihalcik et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: